These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31211678)

  • 21. Molecular study of carbapenemase genes in clinical isolates of Enterobacteriaceae resistant to carbapenems and determining their clonal relationship using pulsed-field gel electrophoresis.
    Shahcheraghi F; Aslani MM; Mahmoudi H; Karimitabar Z; Solgi H; Bahador A; Alikhani MY
    J Med Microbiol; 2017 May; 66(5):570-576. PubMed ID: 28485708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High third-generation cephalosporin resistant Enterobacteriaceae prevalence rate among neonatal infections in Dakar, Senegal.
    Breurec S; Bouchiat C; Sire JM; Moquet O; Bercion R; Cisse MF; Glaser P; Ndiaye O; Ka S; Salord H; Seck A; Sy HS; Michel R; Garin B
    BMC Infect Dis; 2016 Oct; 16(1):587. PubMed ID: 27765017
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Mohanty S; Gaind R
    Indian J Med Microbiol; 2016; 34(4):558-560. PubMed ID: 27934845
    [No Abstract]   [Full Text] [Related]  

  • 24. Antimicrobial susceptibility of pathogens isolated from patients with complicated intra-abdominal infections at five medical centers in Taiwan that continuously participated in the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2006 to 2010.
    Lee YL; Chen YS; Toh HS; Huang CC; Liu YM; Ho CM; Lu PL; Ko WC; Chen YH; Wang JH; Tang HJ; Yu KW; Liu YC; Chuang YC; Liu CE; Hsueh PR
    Int J Antimicrob Agents; 2012 Jun; 40 Suppl():S29-36. PubMed ID: 22749056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbapenem-Resistant Enterobacter cloacae in Patients from the US Veterans Health Administration, 2006-2015.
    Wilson BM; El Chakhtoura NG; Patel S; Saade E; Donskey CJ; Bonomo RA; Perez F
    Emerg Infect Dis; 2017 May; 23(5):878-880. PubMed ID: 28418318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emergence of carbapenem-resistant Enterobacteriaceae in a UK paediatric hospital.
    Drew RJ; Turton JF; Hill RL; Livermore DM; Woodford N; Paulus S; Cunliffe NA
    J Hosp Infect; 2013 Aug; 84(4):300-4. PubMed ID: 23831281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Analysis of the carbapenemase-producing mechanism of Enterobacteriaceae with decreased susceptibility to carbapenems].
    Wang T; Li D; Tao C; Xie Y; Kang M; Chen Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Nov; 33(11):1600-4. PubMed ID: 24273260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenotypic and molecular characteristics of carbapenem-non-susceptible Enterobacteriaceae from a teaching hospital in Wenzhou, southern China.
    Zhou T; Zhang X; Guo M; Ye J; Lu Y; Bao Q; Chi W
    Jpn J Infect Dis; 2013; 66(2):96-102. PubMed ID: 23514904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenotypic and genotypic characteristics of carbapenem-resistant Enterobacteriaceae in a tertiary-level reference hospital in Turkey.
    Baran I; Aksu N
    Ann Clin Microbiol Antimicrob; 2016 Apr; 15():20. PubMed ID: 27048322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and distribution of beta-lactamase coding genes in third-generation cephalosporin-resistant Enterobacteriaceae from bloodstream infections in Cambodia.
    Vlieghe ER; Huang TD; Phe T; Bogaerts P; Berhin C; De Smet B; Peetermans WE; Jacobs JA; Glupczynski Y
    Eur J Clin Microbiol Infect Dis; 2015 Jun; 34(6):1223-9. PubMed ID: 25717021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbapenem-resistant Enterobacteriaceae: biology, epidemiology, and management.
    Temkin E; Adler A; Lerner A; Carmeli Y
    Ann N Y Acad Sci; 2014 Sep; 1323():22-42. PubMed ID: 25195939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Asymptomatic colonization with carbapenem resistant enterobacteriaceae (CRE) in ICU patients and its associated risk factors: Study from North India.
    Datta P; Gupta V; Singla N; Chander J
    Indian J Med Microbiol; 2015; 33(4):612-3. PubMed ID: 26470985
    [No Abstract]   [Full Text] [Related]  

  • 33. The carbapenem-resistant Enterobacteriaceae score: a bedside score to rule out infection with carbapenem-resistant Enterobacteriaceae among hospitalized patients.
    Martin ET; Tansek R; Collins V; Hayakawa K; Abreu-Lanfranco O; Chopra T; Lephart PR; Pogue JM; Kaye KS; Marchaim D
    Am J Infect Control; 2013 Feb; 41(2):180-2. PubMed ID: 22939417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging trends in epidemiology and management of infections caused by carbapenem-resistant Enterobacteriaceae.
    Martirosov DM; Lodise TP
    Diagn Microbiol Infect Dis; 2016 Jun; 85(2):266-75. PubMed ID: 27033631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbapenem-resistant enterobacteriaceae: an emerging problem in children.
    Logan LK
    Clin Infect Dis; 2012 Sep; 55(6):852-9. PubMed ID: 22700827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid emergence and spread of OXA-48-producing carbapenem-resistant Enterobacteriaceae isolates in Belgian hospitals.
    Glupczynski Y; Huang TD; Bouchahrouf W; Rezende de Castro R; Bauraing C; Gérard M; Verbruggen AM; Deplano A; Denis O; Bogaerts P
    Int J Antimicrob Agents; 2012 Feb; 39(2):168-72. PubMed ID: 22115539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Susceptibility to penicillin derivatives among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission.
    Mischnik A; Baumert P; Hamprecht A; Rohde A; Peter S; Feihl S; Knobloch J; Gölz H; Kola A; Obermann B; Querbach C; Willmann M; Gebhardt F; Tacconelli E; Gastmeier P; Seifert H; Kern WV;
    Diagn Microbiol Infect Dis; 2017 Jan; 87(1):71-73. PubMed ID: 27769572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE).
    Goodman KE; Simner PJ; Tamma PD; Milstone AM
    Expert Rev Anti Infect Ther; 2016; 14(1):95-108. PubMed ID: 26535959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of a hospital-wide multifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy.
    Viale P; Tumietto F; Giannella M; Bartoletti M; Tedeschi S; Ambretti S; Cristini F; Gibertoni C; Venturi S; Cavalli M; De Palma A; Puggioli MC; Mosci D; Callea E; Masina R; Moro ML; Lewis RE
    Clin Microbiol Infect; 2015 Mar; 21(3):242-7. PubMed ID: 25658534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Associated factors and outcomes for OXA-232 Carbapenem-resistant Enterobacteriaceae infections in a tertiary care centre in Mexico City: A case-control-control study.
    Torres-González P; Ortiz-Brizuela E; Cervera-Hernandez ME; Bobadilla-Del Valle M; Martínez-Gamboa A; Sifuentes-Osornio J; Ponce-de-Leon A
    Diagn Microbiol Infect Dis; 2016 Oct; 86(2):243-8. PubMed ID: 27519297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.